期刊文献+

基质金属蛋白酶-2的表达与乳腺癌生物学行为及肿瘤转移的关系 被引量:2

Relationship between the expression of matrix metalloproteinase-2 and both biological behaviors and metastases in breast cancer
下载PDF
导出
摘要 目的 :研究乳腺癌中基质金属蛋白酶 -2 (MMP-2 )的表达特点 ,探讨其与乳腺癌生物学行为及肿瘤转移的关系。方法 :应用免疫组织化学 S-P法 ,检测 49例乳腺癌、1 0例癌旁正常组织MMP-2的表达。结果 :乳腺癌组织 MMP-2的表达 (75 .5 % )明显高于癌旁正常组织 (3 0 % ) ,二者之间差异有显著性 (P<0 .0 1 ) ;乳腺癌组织 MMP-2的表达与组织学分级、淋巴结转移密切相关(P<0 .0 5 ) ,而与患者年龄、肿瘤大小、组织学分型、临床分期无关。结论 :MMP-2促进乳腺癌的浸润和转移 ,有可能成为判定乳腺癌生物学行为。 Objective: To study the relationship between expression of matrix metalloproteinase 2 (MMP 2) and biological behaviors and tumor metastases in breast cancer. Methods: The expression of MMP 2 was detected in 49 cases of breast cancer and 10 cases of corresponding non tumor normal tissues by immunohistochemical technique and analyzed. Results: In comparison with corresponding non tumor normal tissues(30%), the expression of MMP 2 in breast cancer (75 5%) was significantly higher than that of control group ( P <0 01). The expression of MMP 2 was correlated with histological grade and lymph node metastases( P <0 05),but there was no correlated with age, tumor size,histological type and clinical stage. Conclusion: MMP 2 may promote tumor invasion and metastases and may act a as indicator to determine biological behaviors, prognosis and clinically therapeutic efficancy of breast cancer.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2002年第3期235-237,共3页 Journal of Jilin University:Medicine Edition
关键词 乳腺肿瘤 基质金属蛋白酶-2 肿瘤转移 免疫组织化学 breast cancer matrix metalloproteinase 2 metastasis immunohistochemistry
  • 相关文献

参考文献2

二级参考文献2

共引文献12

同被引文献16

  • 1孙亚欣,张志超,孙立群,高洪文.基质金属蛋白酶含量及表达与膀胱癌侵袭转移的关系[J].吉林大学学报(医学版),2005,31(1):127-129. 被引量:9
  • 2王璐,李玉林,张丽红,李一雷,何旭,刘湛.基质金属蛋白酶9蛋白及其mRNA在胃癌组织与胃癌细胞中的表达与意义[J].吉林大学学报(医学版),2005,31(2):201-204. 被引量:9
  • 3孟晓萍,王超,孙健,费瑜,崔燕,王莉.急性冠状动脉综合征患者血清基质金属蛋白酶2水平的检测[J].中国动脉硬化杂志,2006,14(4):339-342. 被引量:16
  • 4Amy R Nelson,Barbara Fingleton,Mace L.Rothenberg,et al.MatrixMetalloproteinases:Biologic Activity and Clinical Implications[J].Journal ofClinical Oncology,2000,18(5):1135-1153.
  • 5Mikala Egeblad,Zena Werb.New Functions for the Matrix Metalloproteinases InCancer Progression[J].Cancer,2002,3(2):161-174.
  • 6Stella Maris Ranuncolo,Eduarclo Armanasco,Carlos Cresta,et al.PlasmaMMP-9(92KDa-MMP)Activity is useful in the follow-up and in theassessment of prognosis in Breast Cancer patients[J].Int J Cancer,2003,106(5):745-751.
  • 7Galis ZS,Khatri JJ.Matrix metalloproteinases in vascular remodeling and atherogenesis:the good,the bad,and the ugly[J].Circ Res,2002,90:251-262
  • 8Shah PK.Plaque disruption and thrombosis:potential role of inflammation and infection[J].Cardiol Rev,2000,8 (1):31-39
  • 9Hojo Y,Shimada K.Role of cytokines in acute coronary syndrome[J].Nippon Rinsho,1998,56 (10):2 500-503
  • 10Zeng B,Prasan A,Fung KC,Solanki V,Bruce D,Freedman SB,et al.Elevated circulating levels of matrix,metalloproteinase-9 and -2 in patients with symptomatic coronary artery disease[J].Intern Med J,2005,35 (6):331-335

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部